Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, May 17, 2021
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
[ Mon, May 17th 2021
] - WOPRAI
Fri, May 14, 2021
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
[ Fri, May 14th 2021
] - WOPRAI
Tiago Fauth Maintained (ABCL) at Buy with Decreased Target to $51 on, May 14th, 2021
Tiago Fauth of Credit Suisse, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $53 to $51 on, May 14th, 2021.
Tiago has made no other calls on ABCL in the last 4 months.
There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Tiago's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Tiago
- Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $55 on, Tuesday, March 30th, 2021
- Puneet Souda of "SVB Leerink" Maintained at Buy with Increased Target to $52 on, Monday, February 8th, 2021
